0000899243-22-013721.txt : 20220405 0000899243-22-013721.hdr.sgml : 20220405 20220405160657 ACCESSION NUMBER: 0000899243-22-013721 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220401 FILED AS OF DATE: 20220405 DATE AS OF CHANGE: 20220405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAISBECK DAVID W CENTRAL INDEX KEY: 0001236453 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12626 FILM NUMBER: 22806814 MAIL ADDRESS: STREET 1: C/O CARDINAL HEALTH INC STREET 2: 7000 CARDINAL PLACE CITY: DUBLIN STATE: OH ZIP: 43235 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EASTMAN CHEMICAL CO CENTRAL INDEX KEY: 0000915389 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821] IRS NUMBER: 621539359 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: PO BOX 511 STREET 2: 200 SOUTH WILCOX DRIVE CITY: KINGSPORT STATE: TN ZIP: 37660 BUSINESS PHONE: 4232292000 MAIL ADDRESS: STREET 1: P O BOX 511 B-54D CITY: KINGSPORT STATE: TN ZIP: 37662 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-04-01 0 0000915389 EASTMAN CHEMICAL CO EMN 0001236453 RAISBECK DAVID W 200 SOUTH WILCOX KINGSPORT TN 37660 1 0 0 0 Phantom Stock Units 0.00 2022-04-01 4 A 0 270 0.00 A Common Stock 270 45080 D Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. Includes 485 units credited since October 1, 2021 as hypothetical reinvestment of dividend equivalents. Mark D. Austin, by Power of Attorney 2022-04-05 EX-24 2 attachment1.htm EX-24 DOCUMENT

Exhibit 24

                                POWER OF ATTORNEY

        Know all by these presents that the undersigned hereby constitutes and
appoints each of Mark D. Austin, Clark L. Jordan and Kellye L. Walker, signing
singly, the undersigned's true and lawful attorney-in-fact to:

        (1) execute for and on behalf of the undersigned, in the undersigned's
capacity as an executive officer and/or director of Eastman Chemical Company
(the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934 and the rules thereunder;

        (2) do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and execute any
such Form 3, 4, or 5 and timely file such form with the United States
Securities and Exchange Commission and any stock exchange or similar authority;
and

        (3) take any other action of any type whatsoever in connection with
preparation and filing of disclosure and reports related to ownership and
acquisitions or dispositions of Company securities, including Forms 144
reporting planned sales of Company securities, which, in the opinion of such
attorney-in-fact, may be of benefit to, and in the best interest of, or legally
required by, the undersigned.

        The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 or Rule 144 of the
Securities Exchange Act of 1934.

        This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 4th day of April, 2022.

                                        //David W. Raisbeck//
                                   -------------------------------
                                        David W. Raisbeck